GoodRx Holdings, Inc. (GDRX) is a holding company.
The company, through its subsidiaries, owns and operates a prescription drug price comparison platform using data from local and mail-order pharmacies in the United States. It also provides pharmacy coupons to customers.
The company offers generic and brand name pricing; alerts clients on manufacturer co-pay cards, pharmacy discounts, and state discount programs; and provides tips on slashing drug prices.
It provides prices of drugs in areas of alcohol dependence, allergies, cold, Alzheimer's disease, angina, antibiotics, anticoagulant, antiviral, antiplatelet, anxiety, arrhythmia, arrhythmia, asthma, bipolar disorder, birth control, cancer, cerebral hemorrhage, cholesterol, COPD, depression, dermatology, diabetes, ear, enlarged prostate, epilepsy, eye, fertility, fibromyalgia, flu, gastrointestinal, heart failure, hypertension, hypotension, immune system, insomnia, medical supplies, men's health, mental health, migraine, myasthenia gravis, nausea, nervous system, obesity, obsessive-compulsive disorder, opioid dependence, pain relief, arthritis, panic disorder, Parkinson's disease, PMDD, restless leg syndrome, schizophrenia, seizure, sleep aids, smoking and addiction, smoking cessation, thyroid drugs, Tourette syndrome, trazodone, urology, vaccines, and women's health.
Since its recent IPO in September, this stock has seen a strong trend in price and has been backed by several hedge funds and investment banks. The stock's strong momentum should continue in the coming days.
Entry Point: $57.00
Stop Loss: $53.25
Trading Range: $45.50 - $64.22
Target Price: $62.65
GDRX closed at $38